Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.44 |
| ▸ | GYS1 | P13807 | 4/20 | 0.41 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.40 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6252659 | 0.88 | PTGS2 (0.58) | LRRK2PTGS2GYS1PTGS1 | |
| SCHEMBL7779584 | 0.88 | PTGS2 (0.58) | LRRK2PTGS2MAPTGPR55GYS1 | |
| SCHEMBL7779772 | 0.88 | LRRK2 (0.50) | LRRK2PTGS2PTGS1 | |
| SCHEMBL7779954 | 0.87 | LRRK2 (0.60) | LRRK2PTGS2MAPTMAPK1HTT | |
| SCHEMBL8628027 | 0.87 | GYS1 (0.53) | LRRK2PTGS2GYS1PTGS1 | |
| SCHEMBL7779939 | 0.87 | LRRK2 (0.52) | LRRK2PTGS2GYS1ABCC8KCNJ11 | |
| SCHEMBL7780676 | 0.87 | LRRK2 (0.64) | LRRK2PTGS2PTGS1 | |
| SCHEMBL7778156 | 0.85 | PTGS2 (0.48) | LRRK2PTGS2GYS1ABCC8KCNJ11 | |
| SCHEMBL7779958 | 0.85 | MAPT (0.57) | LRRK2PTGS2MAPTBLMGPR55 | |
| SCHEMBL7779639 | 0.84 | PTGS2 (0.49) | LRRK2PTGS2MAPTMAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0772597-B1 | 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-1127878-A1 | 3,4 - substituted pyrazoles for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2001-08-29 | — | — | EP | disclosed |
| US-6028072-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 2000-02-22 | — | — | US | disclosed |
| US-5756530-A | NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS | G. D. SEARLE & CO. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5580985-A | ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION | G. D. SEARLE & CO. (US) | 1996-12-03 | — | — | US | disclosed |
| US-5486534-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 1996-01-23 | — | — | US | disclosed |